Colorectal Cancer Screening with Fecal Immunochemical Test (FIT) in Samutsakhon Hospital
Keywords:
colorectal cancer, fecal immunochemical tests (fits)Abstract
Objective: This was to study the prevalence and risk factors of colorectal cancer among the population aged 50–75 years in at Samutsakhon Hospital.
Methods: A prospective study was done by collecting data from colorectal cancer screening forms at GI clinic from 1 October 2022 to 31 March 2023, including the results of lower gastrointestinal endoscopy. Data were analyzed using mean, median, SD, range, 95% CI, and odds ratio.
Result: Screening population for colorectal cancer at Samutsakhon Hospital had median age of 61 ± 6, and 60.9% were female. Most comorbidity was hypertension (46.4%) and diabetes was secondly found at 29%.
Lower gastrointestinal endoscopy found that 25 people were normal (36.2%), 27 people had polyps (39.1%), and 5 people had cancer (7.2%). The most common type of polyp was hyperplastic polyp in 13 patients (18.8%) and the most common location of polyps was the sigmoid colon in 13 people (18.8%) followed by hepatic flexure in 6 people (8.7%).
Conclusions: The prevalence of colorectal cancer at Samutsakhon Hospital was to 7.2% from colorectal cancer screening by method of fecal immunochemical test (FIT50). For the behavior of eating vegetables/fruits, It was found that the risk of colon/rectal cancer in those who came for screening was statistically and significantly lower (p-value < .05).
References
Bhandari A, Woodhouse M, Gupta S. Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers. J Investig Med 2017;65 (2):311–15. doi: 10.1136/jim-2016-000229.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424. doi: 10.3322/caac.21492.
Siegel RL, Miller KD, Sauer AG, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020;70(3):145–64. doi: 10.3322/caac.21601.
Montminy EM, Zhou M, Maniscalco L, et al. Contributions of adenocarcinoma and carcinoid tumors to early-onset colorectal cancer incidence rates in the United States. Ann Intern Med 2021;174(2):157–66. doi: 10.7326/M20-0068.
NCI's Division of Cancer Control and Population Sciences (DCCPS). SEER stat database incidence Volume 2021 [internet]. 2021 [cited 2021 February 14]; Available from: URL: http://seer.cancer.gov/seerstat/.
Lin JS, Perdue LA, Henrikson NB, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021;325(19):1978–97. doi:10.1001/jama.2021.4417.
Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg 2015;150(1):17–22. doi: 10.1001/jamasurg.2014.1756.
Morson BC. Evolution of cancer of the colon and rectum. Cancer 1974;34(3):845–9. doi: 10.1002/1097-0142(197409)34:3+<845::aid-cncr2820340710>3.0.co;2-h.
Barré S, Leleu H, Benamouzig R, et al. Cost-effectiveness analysis of alternative colon cancer screening strategies in the context of the French national screening program. Therap Adv Gastroenterol 2020;13. doi: 10.1177/1756284820953364.
Khuhaprema T, Sangrajrang S, Lalitwongsa S, et al. Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme. BMJ Open 2014;4(1):e003671. doi: 10.1136/bmjopen-2013-003671.
Sittipong T, Surawut C. Cororectal cancer screening by fecal immunochemical testing with colonocscopy in Chonburi Province. Chonburi Hospital Journal 2019;44(2):89–95.
Mangas-Sanjuan C, Zapater P, Cubiella J, et al. Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox. United European Gastroenterol J 2018;6(4):622–9. doi: 10.1177/2050640617745458.
Wang H, Wang P, Liu X, et al. Factors predicting the colorectal adenoma detection rate in colonoscopic screening of a Chinese population: A prospective study. Medicine (Baltimore) 2019;98(15):e15103. doi: 10.1097/MD.0000000000015103.
Kastenberg D, Bertiger G, Brogadir S. Bowel preparation quality scales for colonoscopy. World J Gastroenterol 2018;24(26):2833–43. doi: 10.3748/wjg.v24.i26.2833.
Calderwood AH, Jacobson B. Comprehensive validation of the Boston Bowel Preparation Scale. Gastrointest Endosc 2010;72(4):686–92. doi: 10.1016/j.gie.2010.06.068.
Alvarez-Gonzalez MA, Pantaleon MA, Flores-Le Roux JA, et al. Randomized clinical trial: A normocaloric low-fiber diet the day before colonoscopy is the most effective approach to bowel preparation in colorectal cancer screening colonoscopy. Dis Colon Rectum 2019;62(4):491–7. doi: 10.1097/DCR.0000000000001305.
Jiao L, Wang J, Zhao W, et al. Comparison of the effect of 1-day and 2-day low residue diets on the quality of bowel preparation before colonoscopy. Saudi J Gastroenterol 2020;26(3):137–43. doi: 10.4103/sjg.SJG_471_19.
Subramanian V, Ragunath K. Advanced endoscopic imaging: A review of commercially available technologies. Clin Gastroenterol Hepatol 2014;12(3):368–76. doi: 10.1016/j.cgh.2013.06.015.
Soeder M, Turshudzhyan A, Rosenberg L, et al. High- Quality Colonoscopy: A review of Quality indicators and Best Practices. Gastroenterol Insights 2022;13(2):162–72. doi.org/10.3390/gastroent13020017.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ลิขสิทธิ์บทความเป็นของผู้เขียนบทความ แต่หากผลงานของท่านได้รับการพิจารณาตีพิมพ์ลงวารสารแพทย์เขต 4-5 จะคงไว้ซึ่งสิทธิ์ในการตีพิมพ์ครั้งแรกด้วยเหตุที่บทความจะปรากฎในวารสารที่เข้าถึงได้ จึงอนุญาตให้นำบทความในวารสารไปใช้ประโยชน์ได้ในเชิงวิชาการโดยจำเป็นต้องมีการอ้างอิงถึงชื่อวารสารอย่างถูกต้อง แต่ไม่อนุญาตให้นำไปใช้ในเชิงพาณิชย์
